NSG mice were engrafted with MDS patient derived cell line, MDS-L, and treated by DMSO, or FPFT-2216. Mice treated with FPFT-2216 showed a longer survival rate and less infiltration of MDS-L into their bone marrow as compared to their control. Moreover, In vitro experiments confirmed ...